Literature DB >> 31512462

[Down-regulation of miR-381-3p inhibits osteogenic differentiation of mouse embryonic palatal mesenchymal cells in 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin-induced cleft palate of fetal mice].

Heng Jiang1, Xingang Yuan1, Yuexian Fu2.   

Abstract

OBJECTIVE: To investigate the correlation between down-regulation of miR-381-3p and inhibition of osteogenic differentiation of mouse embryonic palatal mesenchymal (MEPM) cells in 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD)-induced cleft palate of fetal mice.
METHODS: Thirty-two pregnant mice were randomly divided into TCDD group and control group, 16 in each group. On embryonic day 10.5 (E10.5), the pregnant mice in TCDD group were orally administrated with TCDD at dosage of 28 μg/kg, while the pregnant mice in control group received equivalent corn oil. The pregnant mice in each group were sacrificed on E13.5 and E14.5, fetal palates were collected for analysis. The expression of miR-381-3p was detected by real-time fluorescent quantitative PCR and the protein expressions of runt- related transcription factor 2 (RUNX2) and osteopontin (OPN) were detected by Western blot. MEPM cells were extracted from fetal palates on E14.5 in control group and passaged. The 3rd passage cells were cultured with TCDD at dosage of 10 nmol/L for 0, 0.5, 1, 2, and 3 days. The expression of miR-381-3p was detected after 0, 0.5, 1, 2, and 3 days and the protein expressions of RUNX2 and OPN were detected after 0, 1, 2, and 3 days. Then, the 3rd passage cells were divided into 4 groups. The MEPM cells were transfected with miR-381-3p inhibitor (inhibitor group), NC inhibitor (NC inhibitor group) and miR-381-3p mimics (mimics group), NC mimics (NC mimics group) for 48 hours, respectively. And the expressions of miR-381-3p and the protein expressions of RUNX2 and OPN were detected.
RESULTS: On E13.5 and E14.5, 96 fetal mice in control group and 92 in TCDD group were obtained. The bilateral palates contacted in control group on E14.5, and a gap between the bilateral palates existed in TCDD group. On E13.5 and E14.5, the relative expressions of miR-381-3p and RUNX2 and OPN proteins were significant lower in TCDD group than in control group ( P<0.05). The relative expression of miR-381-3p at 0.5 and 1 day after TCDD treatment of MEPM cells were significantly lower than that at 0 day ( P<0.05); then, the relative expressions at 2 and 3 days significantly increased, showing no significant difference when compared with that at 0 day ( P>0.05). The relative expressions of RUNX2 and OPN proteins at 1, 2, and 3 days were significantly lower than that at 0 day ( P<0.05). The relative expressions of miR-381-3p and RUNX2 and OPN proteins significantly lower in inhibitor group than in NC inhibitor group ( P<0.05) and higher in mimics group than in NC mimics group ( P<0.05).
CONCLUSION: Down-regulation of miR-381-3p expression may be associated with inhibition of osteogenic differentiation of MEPM cells in TCDD-induced cleft palate of fetal mice.

Entities:  

Keywords:  2, 3, 7, 8- tetrachlorodibenzo-p-dioxin; cleft palate; miR-381-3p; mouse embryonic palatal mesenchymal cells; osteogenic differentiation

Mesh:

Substances:

Year:  2019        PMID: 31512462      PMCID: PMC8355864          DOI: 10.7507/1002-1892.201901028

Source DB:  PubMed          Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi        ISSN: 1002-1892


  21 in total

Review 1.  Signaling-mediated regulation of MicroRNA processing.

Authors:  Jia Shen; Mien-Chie Hung
Journal:  Cancer Res       Date:  2015-02-06       Impact factor: 12.701

Review 2.  [Cleft lip and palate].

Authors:  A Voigt; R J Radlanski; N Sarioglu; G Schmidt
Journal:  Pathologe       Date:  2017-07       Impact factor: 1.011

3.  [Effect of miR-21 down-regulated by H 2O 2 on osteogenic differentiation of MC3T3-E1 cells].

Authors:  Jianqiang Peng; Niansheng Huang; Sheng Huang; Liangping Li; Zemin Ling; Song Jin; Aijun Huang; Kun Lin; Xuenong Zou
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2018-03-15

4.  Disruption of Hedgehog Signaling by Vismodegib Leads to Cleft Palate and Delayed Osteogenesis in Experimental Design.

Authors:  Shixian Zhang; Chengyong Wang; Changfu Xie; Yongzhen Lai; Di Wu; Guowu Gan; Weihui Chen
Journal:  J Craniofac Surg       Date:  2017-09       Impact factor: 1.046

5.  Dioxin disrupts cranial cartilage and dermal bone development in zebrafish larvae.

Authors:  Felipe R Burns; Richard E Peterson; Warren Heideman
Journal:  Aquat Toxicol       Date:  2015-04-16       Impact factor: 4.964

6.  Temporal Expression of miRNAs in Laser Capture Microdissected Palate Medial Edge Epithelium from Tgfβ3(-/-) Mouse Fetuses.

Authors:  Dennis Warner; Jixiang Ding; Partha Mukhopadhyay; Guy Brock; Irina A Smolenkova; Ratnam S Seelan; Cindy L Webb; James L Wittliff; Robert M Greene; M Michele Pisano
Journal:  Microrna       Date:  2015

7.  Down-regulation of Wnt10a by RNA interference inhibits proliferation and promotes apoptosis in mouse embryonic palatal mesenchymal cells through Wnt/β-catenin signaling pathway.

Authors:  Cuijuan Feng; Zhongfei Xu; Zengjian Li; Dan Zhang; Qiang Liu; Li Lu
Journal:  J Physiol Biochem       Date:  2013-05-28       Impact factor: 4.158

8.  TCDD disrupts posterior palatogenesis and causes cleft palate.

Authors:  Tomohiro Yamada; Azumi Hirata; Eri Sasabe; Tomohide Yoshimura; Seiji Ohno; Naoya Kitamura; Tetsuya Yamamoto
Journal:  J Craniomaxillofac Surg       Date:  2013-04-17       Impact factor: 2.078

Review 9.  MicroRNAs in Palatogenesis and Cleft Palate.

Authors:  Christian Schoen; Armaz Aschrafi; Michelle Thonissen; Geert Poelmans; Johannes W Von den Hoff; Carine E L Carels
Journal:  Front Physiol       Date:  2017-04-04       Impact factor: 4.566

10.  MicroRNA-381 Regulates Chondrocyte Hypertrophy by Inhibiting Histone Deacetylase 4 Expression.

Authors:  Weishen Chen; Puyi Sheng; Zhiyu Huang; Fangang Meng; Yan Kang; Guangxin Huang; Zhiqi Zhang; Weiming Liao; Ziji Zhang
Journal:  Int J Mol Sci       Date:  2016-08-23       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.